Minerva Surgical Inc
(UTRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,112 | -21,464 | -18,263 | N/A | N/A |
| Depreciation Amortization | 11,056 | 13,968 | 10,397 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | -132 | N/A | N/A |
| Accounts receivable | 48 | 1,087 | -4,432 | N/A | N/A |
| Accounts payable and accrued liabilities | -881 | 3,300 | -687 | N/A | N/A |
| Other Working Capital | -11,053 | -8,549 | -2,865 | N/A | N/A |
| Other Operating Activity | -625 | -10,721 | 3,741 | 0 | 0 |
| Operating Cash Flow | $-35,567 | $-22,379 | $-12,241 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -73 | -584 | -453 | N/A | N/A |
| Net Acquisitions | N/A | N/A | -15,000 | N/A | N/A |
| Investing Cash Flow | $-73 | $-584 | $-15,453 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 39,531 | 17,959 | N/A | N/A |
| Debt Repayment | N/A | -60,879 | N/A | N/A | N/A |
| Common Stock Issued | 36 | 70,725 | 118 | N/A | N/A |
| Other Financing Activity | -5,000 | -3,165 | 0 | 0 | 0 |
| Financing Cash Flow | $-4,964 | $46,212 | $18,077 | $N/A | $N/A |
| Beginning Cash Position | 48,415 | 25,166 | 34,783 | N/A | N/A |
| End Cash Position | 7,811 | 48,415 | 25,166 | N/A | N/A |
| Net Cash Flow | $-40,604 | $23,249 | $-9,617 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,567 | -22,379 | -12,241 | N/A | N/A |
| Capital Expenditure | -73 | -584 | -453 | N/A | N/A |
| Free Cash Flow | -35,640 | -22,963 | -12,694 | 0 | 0 |